An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal ant... oleh Walter Fiedler, Pau Montesinos, Christoph Schliemann, Jan Middeke, Sumithira Vasu, Christian W. Scholz, Jordi Esteve, Shoubhik Mondal, Björn Rüter, Ute Burkard, Annika Osswald, William Blum